Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation. Sorry, we have no data ...

The long struggle by Boston-based I2o Therapeutics Inc.’s business unit Intarcia Therapeutics to get long-lasting exenatide for diabetes onto the market ended with a final thumbs-down from the U.S.

Dr. Luba Yammine is investigating a treatment that could help smokers both quit and sidestep the weight gain that could stand ...

A recent study published in Annals of Surgery reveals that bariatric surgery can significantly protect kidney function in ...

In people with Type 2 diabetes, obesity, and chronic kidney disease, bariatric or weight loss surgery can significantly ...

However, the overall safety profile of taspoglutide was clearly worse than exenatide with respect to gastrointestinal tolerability, systemic allergic reactions, and injection-site reactions.

Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients ...

The study published in the Annals of Surgery found that bariatric surgery was linked to a 60% lower risk of kidney disease ...

In people with Type 2 diabetes, obesity, and chronic kidney disease, bariatric or weight loss surgery can significantly protect kidney function ...